Germany-based pharmaceutical company Boehringer Ingelheim has partnered up with a blockchain healthcare platform Solve.Care to help patients with diabetes, Solve.Care announced in a press release. Together, the companies are planning to design a blockchain network for data sharing called the Diabetes Care Administration Network.
The platform will be based on Solve.Care’s existing blockchain platform, and it will contain information about patients with diabetes to make coordinating care for patients easier. It’ll also provide information regarding diabetes-associated risks as well as prevention and symptom.
Read the original article on Yahoo News here
